A Shu1, M T Yin, E Stein, S Cremers, E Dworakowski, R Ives, M R Rubin. 1. Department of Medicine, Division of Endocrinology, Metabolic Bone Diseases Unit, College of Physicians and Surgeons, Columbia University, 630 W. 168th St, New York, NY 10032, USA.
Abstract
SUMMARY: We compared skeletal parameters in type 2 diabetic (T2DM) and non-diabetic postmenopausal women. Bone structure by dual energy x-ray absorptiometry (DXA) and HR-pQCT was not different, although procollagen type 1 amino-terminal propeptide (P1NP) and osteocalcin levels were lower in T2DM. INTRODUCTION: T2DM is associated with increased fracture risk, but, paradoxically, with higher cross-sectional bone density (BMD) as measured by DXA. We sought explanations to this puzzle by investigating detailed structural and biochemical skeletal parameters in T2DM. METHODS: Cross-sectional comparison of 25 postmenopausal T2DM women and 25 matched controls using DXA, high-resolution peripheral quantitative computed tomography (HR-pQCT) and biochemical bone turnover markers. RESULTS: BMD by DXA did not differ between T2DM and controls. HR-pQCT assessment also did not differ, with the exception of cortical area at the tibia, which tended to be lower in the diabetics (difference of 12 ± 6 [mean ± SD] mm, p = 0.06). P1NP and osteocalcin levels were lower in T2DM as compared to controls (P1NP, 34.3 ± 16 vs. 57.3 ± 28 ng/ml; p = 0.005; osteocalcin, 4.5 ± 2 vs. 6.2 ± 2 nmol/L; p = 0.001). CONCLUSIONS: Postmenopausal women with T2DM had lower levels of bone formation markers as compared to controls. Aside from a possible decrease in cortical bone area at a weight-bearing site, bone structure was not altered in T2DM. Lower bone turnover may be a skeletal parameter that is present in T2DM.
SUMMARY: We compared skeletal parameters in type 2 diabetic (T2DM) and non-diabetic postmenopausal women. Bone structure by dual energy x-ray absorptiometry (DXA) and HR-pQCT was not different, although procollagen type 1 amino-terminal propeptide (P1NP) and osteocalcin levels were lower in T2DM. INTRODUCTION: T2DM is associated with increased fracture risk, but, paradoxically, with higher cross-sectional bone density (BMD) as measured by DXA. We sought explanations to this puzzle by investigating detailed structural and biochemical skeletal parameters in T2DM. METHODS: Cross-sectional comparison of 25 postmenopausal T2DM women and 25 matched controls using DXA, high-resolution peripheral quantitative computed tomography (HR-pQCT) and biochemical bone turnover markers. RESULTS:BMD by DXA did not differ between T2DM and controls. HR-pQCT assessment also did not differ, with the exception of cortical area at the tibia, which tended to be lower in the diabetics (difference of 12 ± 6 [mean ± SD] mm, p = 0.06). P1NP and osteocalcin levels were lower in T2DM as compared to controls (P1NP, 34.3 ± 16 vs. 57.3 ± 28 ng/ml; p = 0.005; osteocalcin, 4.5 ± 2 vs. 6.2 ± 2 nmol/L; p = 0.001). CONCLUSIONS: Postmenopausal women with T2DM had lower levels of bone formation markers as compared to controls. Aside from a possible decrease in cortical bone area at a weight-bearing site, bone structure was not altered in T2DM. Lower bone turnover may be a skeletal parameter that is present in T2DM.
Authors: M Inaba; Y Nishizawa; K Mita; Y Kumeda; M Emoto; T Kawagishi; E Ishimura; K Nakatsuka; A Shioi; H Morii Journal: Osteoporos Int Date: 1999 Impact factor: 4.507
Authors: Jackie A Clowes; Heather C Allen; Donna M Prentis; Richard Eastell; Aubrey Blumsohn Journal: J Clin Endocrinol Metab Date: 2003-10 Impact factor: 5.958
Authors: Elsa S Strotmeyer; Jane A Cauley; Ann V Schwartz; Michael C Nevitt; Helaine E Resnick; Joseph M Zmuda; Douglas C Bauer; Frances A Tylavsky; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman Journal: J Bone Miner Res Date: 2004-03-15 Impact factor: 6.741
Authors: M Inaba; M Terada; H Koyama; O Yoshida; E Ishimura; T Kawagishi; Y Okuno; Y Nishizawa; S Otani; H Morii Journal: J Bone Miner Res Date: 1995-07 Impact factor: 6.741
Authors: Emily M Stein; X Sherry Liu; Thomas L Nickolas; Adi Cohen; Valerie Thomas; Donald J McMahon; Chiyuan Zhang; Perry T Yin; Felicia Cosman; Jeri Nieves; X Edward Guo; Elizabeth Shane Journal: J Bone Miner Res Date: 2010-06-18 Impact factor: 6.741
Authors: E W Yu; M S Putman; N Derrico; G Abrishamanian-Garcia; J S Finkelstein; M L Bouxsein Journal: Osteoporos Int Date: 2014-11-15 Impact factor: 4.507
Authors: Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla Journal: J Bone Miner Res Date: 2014-04 Impact factor: 6.741
Authors: Lamya Karim; Julia Moulton; Miranda Van Vliet; Kelsey Velie; Ann Robbins; Fatemeh Malekipour; Ayesha Abdeen; Douglas Ayres; Mary L Bouxsein Journal: Bone Date: 2018-05-30 Impact factor: 4.398
Authors: J Paccou; M H Edwards; K A Ward; K A Jameson; C L Moss; N C Harvey; E M Dennison; C Cooper Journal: Osteoporos Int Date: 2015-04-24 Impact factor: 4.507
Authors: Jessica F Starr; Leonardo C Bandeira; Sanchita Agarwal; Ankit M Shah; Kyle K Nishiyama; Yizhong Hu; Donald J McMahon; X Edward Guo; Shonni J Silverberg; Mishaela R Rubin Journal: J Bone Miner Res Date: 2018-06-15 Impact factor: 6.741